Financial reports
10-Q
2024 Q3
Quarterly report
29 Oct 24
10-Q
2024 Q2
Quarterly report
30 Jul 24
ARS
2023 FY
Annual report to shareholders
29 Apr 24
10-Q
2024 Q1
Quarterly report
29 Apr 24
10-K
2023 FY
Annual report
23 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
8 May 23
10-K
2022 FY
Annual report
16 Mar 23
Current reports
8-K
GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
29 Oct 24
8-K
GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
30 Jul 24
8-K
Submission of Matters to a Vote of Security Holders
24 Jun 24
8-K
Entry into a Material Definitive Agreement
29 Apr 24
8-K
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
29 Apr 24
8-K
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
20 Feb 24
8-K
GeneDx Announces Preliminary 2023 Financial Results
8 Jan 24
8-K
GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
30 Oct 23
8-K
GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights
8 Aug 23
8-K
Departure of Directors or Certain Officers
24 Jul 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
30 Apr 24
424B5
Prospectus supplement for primary offering
29 Apr 24
S-8
Registration of securities for employees
23 Feb 24
S-8
Registration of securities for employees
8 Aug 23
S-8
Registration of securities for employees
25 Apr 23
424B5
Prospectus supplement for primary offering
30 Jan 23
424B5
Prospectus supplement for primary offering
30 Jan 23
424B5
Prospectus supplement for primary offering
26 Jan 23
S-8
Registration of securities for employees
9 Jan 23
424B3
Prospectus supplement
7 Sep 22
Proxies
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
DEFA14A
Additional proxy soliciting materials
6 Jun 23
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
31 Mar 23
PRE 14A
Preliminary proxy
21 Mar 23
DEFA14A
Additional proxy soliciting materials
18 Apr 22
DEFM14A
Proxy related to merger
31 Mar 22
PREM14A
Preliminary proxy related to merger
15 Mar 22
DEFA14A
Additional proxy soliciting materials
15 Mar 22
Other
EFFECT
Notice of effectiveness
8 Sep 22
EFFECT
Notice of effectiveness
8 Sep 22
CORRESP
Correspondence with SEC
2 Sep 22
CORRESP
Correspondence with SEC
2 Sep 22
UPLOAD
Letter from SEC
31 Aug 22
UPLOAD
Letter from SEC
31 Aug 22
EFFECT
Notice of effectiveness
12 May 22
CORRESP
Correspondence with SEC
9 May 22
UPLOAD
Letter from SEC
5 May 22
EFFECT
Notice of effectiveness
25 Mar 22
Ownership
4
SCHOOL OF MEDICINE AT MOUNT SINAI ICAHN
4 Nov 24
SC 13D/A
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
4 Nov 24
144
Notice of proposed sale of securities
31 Oct 24
4
Kevin Feeley
31 Oct 24
4
Katherine Stueland
31 Oct 24
144
Notice of proposed sale of securities
29 Oct 24
144
Notice of proposed sale of securities
29 Oct 24
4
Jason Ryan
17 Oct 24
4
JOSHUA RUCH
17 Oct 24
144
Notice of proposed sale of securities
20 Sep 24